FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Dr. Reddy's Laboratories IBU Ibuprofen Tablets Recall

IBU Ibuprofen Tablets, USP, 600 mg, Rx Only, Distributor: Dr

Dr. Reddy's Laboratories, Inc. · Princeton, NJ

Risk level
Class II
Reported by FDA
Sep 4, 2024
Recall ID
D-0645-2024
Check your lot numberHow we source this data

Summary

Dr. Reddy's Laboratories recalled IBU Ibuprofen Tablets starting Aug 6, 2024. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0645-2024 on Sep 4, 2024. Reason: Failed impurities/degradation specifications: results for unknown impurity, were 0.13% and 0.11% respectively, exceeding the 0.10% specification limit. Status: Ongoing.

Why it was recalled

Failed impurities/degradation specifications: results for unknown impurity, were 0.13% and 0.11% respectively, exceeding the 0.10% specification limit.

Product description

IBU Ibuprofen Tablets, USP, 600 mg, Rx Only, Distributor: Dr. Reddy's Laboratories Inc., Princeton, NJ 08540, Made in India, a)NDC 55111-683-01 - 100 Tablets per bottle, b)NDC 5511-683-05 - 500 Tablets per bottle.

Lot numbers, UPCs & expiration codes

a)NDC 55111-683-01 Lots C2207527, Exp 5/31/2026; C2210864, Exp 9/30/2026; C2213018, Exp 11/30/2026. b)NDC 5511-683-05 Lots C2207528, Exp 5/31/2026; C2210860, Exp 9/30/2026; C2213016, C2213017, Exp 11/30/2026; C2301852, C2302056, C2302057, Exp 1/31/2027.

Where it was sold

Nationwide in the USA and Puerto Rico

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0645-2024
Classification
Class II
Status
Ongoing
Recall initiated
Aug 6, 2024
FDA report date
Sep 4, 2024
Quantity
31,802 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Dr. Reddy's Laboratories, Inc.

Original FDA data

Every field from FDA enforcement report D-0645-2024, exactly as published.

Show all FDA fields
City
Princeton
State
NJ
Status
Ongoing
Country
United States
Event ID
95098
Address
107 College Rd E
Code information
a)NDC 55111-683-01 Lots C2207527, Exp 5/31/2026; C2210864, Exp 9/30/2026; C2213018, Exp 11/30/2026. b)NDC 5511-683-05 Lots C2207528, Exp 5/31/2026; C2210860, Exp 9/30/2026; C2213016, C2213017, Exp 11/30/2026; C2301852, C2302056, C2302057, Exp 1/31/2027.
Postal code
08540-6623
Report date
Sep 4, 2024
Product type
Drugs
Recall number
D-0645-2024
Classification
Class II
Recalling firm
Dr. Reddy's Laboratories, Inc.
Product quantity
31,802 bottles
Reason for recall
Failed impurities/degradation specifications: results for unknown impurity, were 0.13% and 0.11% respectively, exceeding the 0.10% specification limit.
Voluntary / mandated
Voluntary: Firm initiated
Product description
IBU Ibuprofen Tablets, USP, 600 mg, Rx Only, Distributor: Dr. Reddy's Laboratories Inc., Princeton, NJ 08540, Made in India, a)NDC 55111-683-01 - 100 Tablets per bottle, b)NDC 5511-683-05 - 500 Tablets per bottle.
Distribution pattern
Nationwide in the USA and Puerto Rico
Recall initiation date
Aug 6, 2024
Center classification date
Aug 26, 2024

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0645-2024, published Sep 4, 2024. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls